Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$460M |
| 2 |
GE Aerospace
GE
|
$402M |
| 3 |
CELG
Celgene Corp
CELG
|
$381M |
| 4 |
Bristol-Myers Squibb
BMY
|
$379M |
| 5 |
Johnson & Johnson
JNJ
|
$358M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$307M |
| 2 |
Costco
COST
|
$279M |
| 3 |
Lowe's Companies
LOW
|
$273M |
| 4 |
Microsoft
MSFT
|
$243M |
| 5 |
Chevron
CVX
|
$225M |
Sector Composition
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.12% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Charles River Laboratories
CRL
$7.99B
| $236M | 0.21% |
1,664,500
-221,200
| -12% | -$31.4M |
|
102
Markel Group
MKL
$24.7B
| $236M | 0.21% |
216,371
-12,040
| -5% | -$13.1M |
|
103
CSX Corp
CSX
$60.2B
| $235M | 0.21% |
3,036,900
+2,231,500
| +277% | +$173M |
|
104
WIX.com
WIX
$8.05B
| $233M | 0.2% |
1,637,300
-200,400
| -11% | -$28.5M |
|
105
Scotiabank
BNS
$78.1B
| $232M | 0.2% |
4,268,600
+358,200
| +9% | +$19.5M |
|
106
Sinclair Inc
SBGI
$980M
| $230M | 0.2% |
4,291,227
+1,072,664
| +33% | +$57.5M |
|
107
Ericsson
ERIC
$26.2B
| $222M | 0.2% |
23,362,900
+2,259,100
| +11% | +$21.5M |
|
108
Wells Fargo
WFC
$258B
| $221M | 0.19% |
4,661,211
+1,816,711
| +64% | +$86M |
|
109
Kinross Gold
KGC
$26.6B
| $220M | 0.19% |
56,711,483
-1,997,173
| -3% | -$7.75M |
|
110
Ryanair
RYAAY
$32.9B
| $218M | 0.19% |
3,396,619
-35,000
| -1% | -$2.24M |
|
|
ALXN
111
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $215M | 0.19% |
1,642,542
+840,742
| +105% | +$110M |
|
112
Medtronic
MDT
$118B
| $215M | 0.19% |
+2,206,541
| New | +$215M |
|
|
HZNP
113
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $211M | 0.19% |
8,754,275
+896,500
| +11% | +$21.6M |
|
114
Newmont
NEM
$82.8B
| $208M | 0.18% |
5,403,498
+28,098
| +0.5% | +$1.08M |
|
115
Comcast
CMCSA
$125B
| $207M | 0.18% |
+4,902,776
| New | +$207M |
|
116
Cogent Communications
CCOI
$1.78B
| $203M | 0.18% |
3,423,700
+47,300
| +1% | +$2.81M |
|
117
HSBC
HSBC
$224B
| $203M | 0.18% |
4,866,027
+1,880,300
| +63% | +$77M |
|
118
Altice USA
ATUS
$1.12B
| $203M | 0.18% |
8,340,700
-143,300
| -2% | -$3.49M |
|
119
Berkshire Hathaway Class B
BRK.B
$1.08T
| $199M | 0.18% |
935,100
-401,800
| -30% | -$85.7M |
|
120
Telus
TU
$25.1B
| $199M | 0.18% |
5,398,100
-275,500
| -5% | -$10.2M |
|
121
AvalonBay Communities
AVB
$27.2B
| $196M | 0.17% |
964,614
-504,300
| -34% | -$102M |
|
122
Sony
SONY
$162B
| $194M | 0.17% |
3,712,000
+573,000
| +18% | +$30M |
|
123
CME Group
CME
$97.1B
| $192M | 0.17% |
991,419
-876,789
| -47% | -$170M |
|
124
Roku
ROKU
$14.5B
| $192M | 0.17% |
2,115,800
-739,800
| -26% | -$67M |
|
125
Douglas Emmett
DEI
$2.7B
| $191M | 0.17% |
4,798,800
+706,200
| +17% | +$28.1M |
|